Placebo-controlled trial of cytisine for smoking cessation.
BACKGROUND: Cytisine, a partial agonist that binds with high affinity to the α(4)β(2) nicotinic acetylcholine receptor, is a low-cost treatment that may be effective in aiding smoking cessation. This study assessed the efficacy and safety of cytisine as compared with placebo. METHODS: We conducted a...
Hlavní autoři: | West, R, Zatonski, W, Cedzynska, M, Lewandowska, D, Pazik, J, Aveyard, P, Stapleton, J |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2011
|
Podobné jednotky
-
Smoking cessation 3: Nicotinic partial agonists in smoking cessation - Varenicline and cytisine
Autor: Aveyard, P, a další
Vydáno: (2009) -
Cytisine and the failure to market and regulate for human health.
Autor: Aveyard, P, a další
Vydáno: (2013) -
Potential uses of cytisine for smoking cessation in menopausal women – literature summary
Autor: Francisco Rubio Rubio, a další
Vydáno: (2023-04-01) -
Cytisine versus varenicline for smoking cessation in a primary care setting: a randomized non-inferiority trial
Autor: Oreskovic, T, a další
Vydáno: (2023) -
Cancer and smoking cessation
Autor: Magdalena Cedzynska, a další
Vydáno: (2019-10-01)